CureLauncher, the US-based matching service for clinical trials, has forged an exclusive partnership with the National Stroke Association in an effort to improve outcomes for what is now the fourth-leading cause of death in the United States.
National Stroke Association members and online visitors will now be directed to http://www.curelauncher.com, where specially trained relationship managers will help them locate a clinical trial that may offer access to a new diagnostic test, treatment or rehabilitative approach to their condition.
Set up in 1984, the National Stroke Association is an educational, prevention and advocacy group for individuals and their families, as well as healthcare professionals, confronting health issues related to strokes.
It is the only national non-profit healthcare organisation in the US focusing 100% of its resources and attention on stroke, the association noted.
Challenging condition
“Together, we can make progress in preventing, treating and understanding this challenging condition that impacts so many American families,” commented Jim Baranski, chief executive officer of the National Stroke Association on the partnership with CureLauncher.
“In particular, clinical medical research is bringing us new diagnostic techniques to identify individuals at risk for stroke, as well as life strategies and other approaches to prevention,” Baranski pointed out.
